MIRA Pharmaceuticals shares are trading higher after the company announced results from the completed 7-day dose-range finding toxicology and toxicokinetic studies of MIRA-55 in rats and dogs.

Benzinga Newsdesk www.benzinga.com Positive 94.3%

Neg 0% Neu 0% Pos 94.3%

Comments

No comments yet. Be the first!